TransMedics Group, Inc. Increase (Decrease) in Accounts Receivable
TransMedics Group, Inc. (TMDX) reported Increase (Decrease) in Accounts Receivable of $19.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- TransMedics Group, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $13.43M.
- TransMedics Group, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $6.52M, a 85.23% decline year-over-year.
- TransMedics Group, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $3.58M, a 54.32% decline year-over-year.
- TransMedics Group, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$24.15M, a 373.82% decline year-over-year.
- TransMedics Group, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$13.95M, a 140.66% decline from fiscal 2024.
- TransMedics Group, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $34.31M, a 1.46% increase from fiscal 2023.
- TransMedics Group, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $33.82M, a 55.99% increase from fiscal 2022.
- TransMedics Group, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $21.68M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $19.95M 10-Q · filed 2026-08-04 | $23.53M derived: sum of 3 quarters · filed 2026-08-04 | -$618.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $6.52M 10-Q · filed 2026-05-05 | $10.10M derived: sum of 2 quarters · filed 2026-05-05 | -$14.05M derived: sum of 3 quarters · filed 2026-05-05 | -$51.56M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$20.57M derived: sum of 2 quarters · filed 2026-02-24 | -$58.08M derived: sum of 3 quarters · filed 2026-08-04 | -$13.95M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$24.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$61.67M derived: sum of 2 quarters · filed 2026-08-04 | -$17.53M 10-Q · filed 2025-10-29 | -$9.69M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$37.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.62M 10-Q · filed 2026-08-04 | $14.46M derived: sum of 3 quarters · filed 2026-08-04 | $23.28M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $44.13M 10-Q · filed 2026-05-05 | $51.98M derived: sum of 2 quarters · filed 2026-05-05 | $60.79M derived: sum of 3 quarters · filed 2026-05-05 | $60.04M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $16.66M derived: sum of 2 quarters · filed 2026-02-24 | $15.90M derived: sum of 3 quarters · filed 2026-02-24 | $34.31M 10-K · filed 2026-02-24 |
| 2024-09-30 | $8.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $8.06M derived: sum of 2 quarters · filed 2025-10-29 | $26.47M 10-Q · filed 2025-10-29 | $29.29M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$757.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $17.65M 10-Q · filed 2025-07-30 | $20.47M derived: sum of 3 quarters · filed 2026-02-24 | $31.60M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $18.41M 10-Q · filed 2025-05-08 | $21.23M derived: sum of 2 quarters · filed 2026-02-24 | $32.36M derived: sum of 3 quarters · filed 2026-02-24 | $41.26M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $13.95M derived: sum of 2 quarters · filed 2026-02-24 | $22.85M derived: sum of 3 quarters · filed 2026-02-24 | $33.82M 10-K · filed 2026-02-24 |
| 2023-09-30 | $11.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $20.04M derived: sum of 2 quarters · filed 2024-10-29 | $31.00M 10-Q · filed 2024-10-29 | $36.39M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $19.86M 10-Q · filed 2024-08-01 | $25.25M derived: sum of 3 quarters · filed 2025-02-27 | $34.41M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $10.96M 10-Q · filed 2024-05-02 | $16.35M derived: sum of 2 quarters · filed 2025-02-27 | $25.51M derived: sum of 3 quarters · filed 2025-02-27 | $26.84M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $14.55M derived: sum of 2 quarters · filed 2025-02-27 | $15.87M derived: sum of 3 quarters · filed 2025-02-27 | $21.68M 10-K · filed 2025-02-27 |
| 2022-09-30 | $9.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $10.48M derived: sum of 2 quarters · filed 2023-11-08 | $16.29M 10-Q · filed 2023-11-08 | $18.10M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $7.13M 10-Q · filed 2023-08-04 | $8.94M derived: sum of 3 quarters · filed 2024-02-27 | $6.85M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $5.80M 10-Q · filed 2023-05-04 | $7.61M derived: sum of 2 quarters · filed 2024-02-27 | $5.52M derived: sum of 3 quarters · filed 2024-02-27 | $4.38M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$280.00K derived: sum of 2 quarters · filed 2024-02-27 | -$1.42M derived: sum of 3 quarters · filed 2024-02-27 | -$840.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$3.23M derived: sum of 2 quarters · filed 2022-11-04 | -$2.65M 10-Q · filed 2022-11-04 | -$1.96M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$560.00K 10-Q · filed 2022-08-03 | $130.00K derived: sum of 3 quarters · filed 2023-02-27 | $1.79M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $583.00K 10-Q · filed 2022-05-05 | $1.27M derived: sum of 2 quarters · filed 2023-02-27 | $2.94M derived: sum of 3 quarters · filed 2023-02-27 | $1.22M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $690.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $2.35M derived: sum of 2 quarters · filed 2023-02-27 | $640.00K derived: sum of 3 quarters · filed 2023-02-27 | $218.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$50.00K derived: sum of 2 quarters · filed 2021-11-09 | -$472.00K 10-Q · filed 2021-11-09 | -$404.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$2.13M 10-Q · filed 2021-08-06 | -$2.07M derived: sum of 3 quarters · filed 2021-05-07 | -$2.65M derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | -$422.00K 10-Q · filed 2021-05-07 | -$354.00K derived: sum of 2 quarters · filed 2021-05-07 | -$937.00K derived: sum of 3 quarters · filed 2021-05-07 | $998.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$515.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.42M derived: sum of 3 quarters · filed 2021-03-11 | $3.17M 10-K · filed 2021-03-11 |
| 2019-09-28 | -$583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.35M derived: sum of 2 quarters · filed 2020-08-07 | $3.10M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.68M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $1.75M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $2.51M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $2.98M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $802.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.82M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $1.02M 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |